GlassScriptPhysician profile
Sonyoung Seo-Patel
NPI 1124281134
$1,250.30
in general payments reported to CMS, 2019-2025
21 companies · $488 in 2025
The $488 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.70 · 2021: $113 · 2022: $126 · 2023: $288 · 2024: $207 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.24 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $266.70 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $221.58 | 2023-2025 | Veozah |
| Abbvie INC. | $139.28 | 2019-2024 | Qulipta, Ubrelvy, Orilissa |
| Sumitomo Pharma America, INC. | $108.47 | 2024-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $68.44 | 2023-2025 | Gardasil 9 |
| Daiichi Sankyo INC. | $59.45 | 2019-2023 | Injectafer |
| Gynesonics, INC. | $53.39 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Novo Nordisk INC | $48.39 | 2023-2025 | Wegovy |
| Organon LLC | $42.54 | 2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $41.02 | 2025 | Zurzuvae |
| Millicent US INC | $32.58 | 2025 | Femlyv, Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $31.13 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $19.83 | 2025 | Qelbree |
| Lilly USA, LLC | $19.40 | 2025 | Zepbound |
| Vertex Pharmaceuticals Incorporated | $16.31 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.62 | 2022 | |
| Shield Therapeutics INC | $14.18 | 2023 | Accrufer |
| Amgen INC. | $13.62 | 2023 | Prolia, Evenity |
| Optumhealth Care Solutions, LLC | $13.48 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Mayne Pharma Commercial LLC | $13.05 | 2023 | |
| Pfizer INC. | $12.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonyoung Seo-Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.